title: Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.
abstract: Lineage-specific differentiation potential varies among different human pluripotent stem cell (hPSC) lines, becoming therefore highly desirable to prospectively know which hPSC lines exhibit the highest differentiation potential for a certain lineage. We have compared the hematopoietic potential of 14 human embryonic stem cell (hESC)/induced pluripotent stem cell (iPSC) lines. The emergence of hemogenic progenitors, primitive and mature blood cells, and colony-forming unit (CFU) potential was analyzed at different time points. Significant differences in the propensity to differentiate toward blood were observed among hPSCs: some hPSCs exhibited good blood differentiation potential, whereas others barely displayed blood-differentiation capacity. Correlation studies revealed that the CFU potential robustly correlates with hemogenic progenitors and primitive but not mature blood cells. Developmental progression of mesoendodermal and hematopoietic transcription factors expression revealed no correlation with either hematopoietic initiation or maturation efficiency. Microarray studies showed distinct gene expression profile between hPSCs with good versus poor hematopoietic potential. Although neuroectoderm-associated genes were downregulated in hPSCs prone to hematopoietic differentiation many members of the Nodal/Activin signaling were upregulated, suggesting that this signaling predicts those hPSC lines with good blood-differentiation potential. The association between Nodal/Activin signaling and the hematopoietic differentiation potential was confirmed using loss- and gain-of-function functional assays. Our data reinforce the value of prospective comparative studies aimed at determining the lineage-specific differentiation potential among different hPSCs and indicate that Nodal/Activin signaling seems to predict those hPSC lines prone to hematopoietic specification.
authors.affiliation: Andalusian Stem Cell Bank, Centro de Investigación Biomédica, Consejería de Salud-Universidad de Granada, Granada, Spain. veronica.ramos@juntadeandalucia.es
authors.forename: Veronica
authors.initials: V
authors.lastname: Ramos-Mejia
authors.forename: Gustavo J
authors.initials: GJ
authors.lastname: Melen
authors.forename: Laura
authors.initials: L
authors.lastname: Sanchez
authors.forename: Ivan
authors.initials: I
authors.lastname: Gutierrez-Aranda
authors.forename: Gertrudis
authors.initials: G
authors.lastname: Ligero
authors.forename: Jose L
authors.initials: JL
authors.lastname: Cortes
authors.forename: Pedro J
authors.initials: PJ
authors.lastname: Real
authors.forename: Clara
authors.initials: C
authors.lastname: Bueno
authors.forename: Pablo
authors.initials: P
authors.lastname: Menendez
mesh_terms: D028341:Activins / Q000378:metabolism* / Q000494:pharmacology; D002454:Cell Differentiation; D019070:Cell Lineage; D020869:Gene Expression Profiling; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D039904:Pluripotent Stem Cells / Q000166:cytology*; D015398:Signal Transduction
chemical_list: D028341:Activins